A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study. (Q34781699)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study. |
scientific article |
Statements
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study (English)
Matthew A Powell
Michael W Sill
Paul J Goodfellow
Heather A Lankes
Yvette Jeske
Robert S Mannel
Monique A Spillman
Paula S Lee
James S Hoffman
D Scott McMeekin
1 reference
1 reference
1 reference
1 reference